Meta-analysis of Unguided Deescalation of Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

被引：0
|
作者：
Mohamed, Mohamed M. G. [1 ]
Shaikh, Safia [1 ]
Osman, Mohammed [2 ]
Kheiri, Babikir [2 ]
机构：
[1] SSM Hlth St Marys Hosp, Internal Med Dept, 6420 Clayton Rd,Suite 2218, St Louis, MO 63117 USA
[2] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR USA
来源：
TH OPEN | 2022年 / 06卷 / 02期
关键词：
ACUTE MYOCARDIAL-INFARCTION; DE-ESCALATION; CLOPIDOGREL;
D O I：
10.1055/a-1827-8128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e144 / e146
页数：3
相关论文
共 50 条
  • [41] Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials
    Zhou, Yijiang
    Wang, Yanwei
    Wu, Yutao
    Huang, Chaoyang
    Yan, Hui
    Zhu, Weiguo
    Xu, Weiwei
    Zhang, Li
    Zhu, Jianhua
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [42] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    张步春
    车文良
    刘伟静
    徐亚伟
    SouthChinaJournalofCardiology, 2010, 11 (04) : 238 - 245
  • [43] Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
    Shih-Chin Chen
    Fei-Yuan Hsiao
    Chii-Ming Lee
    William Wei-Yuan Hsu
    Churn-Shiouh Gau
    BMC Cardiovascular Disorders, 14
  • [44] Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
    Chen, Shih-Chin
    Hsiao, Fei-Yuan
    Lee, Chii-Ming
    Hsu, William Wei-Yuan
    Gau, Churn-Shiouh
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [45] Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
    Han, Yan
    Yuan, Xiaohang
    Hu, Xin
    Fang, Yan
    Jiang, Mengting
    Feng, Huanhuan
    Gao, Lei
    CARDIOLOGY JOURNAL, 2023, 30 (04) : 556 - 566
  • [46] Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kuno, Toshiki
    Ueyama, Hiroki
    Takagi, Hisato
    Ando, Tomo
    Numasawa, Yohei
    Briasoulis, Alexandros
    Fox, John
    Bangalore, Sripal
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04) : 521 - 527
  • [47] Contemporary Antiplatelet Treatment in Acute Coronary Syndrome Patients with Impaired Renal Function Undergoing Percutaneous Coronary Intervention
    Davlouros, Periklis
    Xanthopoulou, Ioanna
    Goudevenos, John
    Hamilos, Michalis
    Vavuranakis, Emmanouil
    Sitafidis, George
    Kanakakis, Ioannis
    Deftereos, Spyridon
    Alexopoulos, Dimitrios
    CARDIOLOGY, 2017, 138 (03) : 186 - 194
  • [48] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
    Roffman, David S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
  • [49] Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations
    Weintraub, William S.
    Mandel, Leonid
    Weiss, Sandra A.
    PHARMACOECONOMICS, 2013, 31 (11) : 959 - 970
  • [50] Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention
    Mihajlovic, Miroslav
    Marinkovic, Milan
    Koziel, Monika
    Mujovic, Nebojsa
    Lip, Gregory Y. H.
    Potpara, Tatjana S.
    KARDIOLOGIA POLSKA, 2020, 78 (06) : 512 - 519
12345